<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="100890">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01983059</url>
  </required_header>
  <id_info>
    <org_study_id>SLVTS-SASL-35</org_study_id>
    <nct_id>NCT01983059</nct_id>
  </id_info>
  <brief_title>Swiss Liver Venous Thrombosis Study</brief_title>
  <acronym>SLVTS-SASL-35</acronym>
  <official_title>A Multicenter Prospective Observational Cohort Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital Inselspital, Berne</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Foundation for Liver Research</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University Hospital Inselspital, Berne</source>
  <oversight_info>
    <authority>Switzerland: Ethikkommission</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The Liver Venous Thrombosis Study is a prospective observational cohort study aimed at
      collecting clinical data, patient reported outcomes and biological samples of all patients
      who have been newly and previously diagnosed with liver venous thrombosis in one of the
      participating hospitals in-and out-patients clinics of the participating centers in
      Switzerland. All new patients diagnosed with liver venous thrombosis or patients who are
      currently being treated in one of the participating centers, will be asked to participate in
      the study.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Background

      Outcome measures:

      Primary: Liver venous thrombosis recanalization

      Secondary: Thrombosis progression, Overall mortality, Major bleeding, Ascites

      Objective

        -  To start a prospective observational cohort study of Liver Venous Thrombosis patients
           in Switzerland from their primary diagnosis and already diagnosed patients.

        -  To examine long-term medical outcomes in patients with liver venous thrombosis in
           Switzerland by defining incidence, risk factors and treatment results

        -  To prospectively collect data on medical history, serious comorbidities, baseline
           clinical parameters, imaging results, pathology results, tumor characteristics,
           treatment, treatment outcomes, hospital stays, interventions and complications.

        -  To build a bio-bank with blood of these patients

      Methods

      N/A
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>March 2014</start_date>
  <completion_date type="Anticipated">December 2019</completion_date>
  <primary_completion_date type="Anticipated">December 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <study_design>Observational Model: Cohort, Time Perspective: Prospective</study_design>
  <primary_outcome>
    <measure>Number of patients with liver venous thrombosis recanalization</measure>
    <time_frame>End of study, expected to be on average after 5 years</time_frame>
    <safety_issue>Yes</safety_issue>
  </primary_outcome>
  <secondary_outcome>
    <measure>Number of patients with thrombosis recurrence</measure>
    <time_frame>End of study, expected to be on average after 5 years</time_frame>
    <safety_issue>Yes</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Overall mortality</measure>
    <time_frame>End of study, expected to be on average after 5 years</time_frame>
    <safety_issue>Yes</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of patients with major bleeding</measure>
    <time_frame>End of study, expected to be on average after 5 years</time_frame>
    <safety_issue>Yes</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of patients with ascites</measure>
    <time_frame>End of study, expected to be on average after 5 years</time_frame>
    <safety_issue>Yes</safety_issue>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">500</enrollment>
  <condition>Observational Study</condition>
  <arm_group>
    <arm_group_label>Patients with Liver Venous Thrombosis</arm_group_label>
    <description>NA</description>
  </arm_group>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      blood, serum, plasma, stool and urine samples
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Population of adolescent, adults and elderly
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age ≥ 18 years

          -  Admitted in  hospital or attend outpatient clinic

          -  With objectively confirmed portal vein thrombosis and/or hepatic vein thrombosis

          -  Subject or parent/guardian willing to provide informed consent

        Exclusion Criteria

          -  Thrombosis limited to mesenteric or splenic vein

          -  Inability to sign consent form

          -  Follow-up not possible

          -  Cardiovascular, tumoral, pulmonary with life expectancy estimated to be less than 6
             months
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Andreas Ayukebi, Dr. med.</last_name>
    <role>Study Chair</role>
    <affiliation>Inselspital (University Hospital) Bern</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Andrea De Gottardi, PD Dr. med.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Inselspital (University Hospital) Bern</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Andreas Ayukebi, Dr. med.</last_name>
    <phone>031 632 5954</phone>
    <email>andreas.ayukebi@insel.ch</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Andrea De Gottardi, PD Dr. med.</last_name>
    <phone>031 632 3570</phone>
    <email>andrea.degottardi@ikp.unibe.ch</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Klinik für Gastroenterologie und Hepatology, Universtätspital Basel</name>
      <address>
        <city>Basel</city>
        <state>Kanton Basel</state>
        <zip>4031</zip>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Department of Clinical Reserach, Hepatology Research Group</name>
      <address>
        <city>Bern</city>
        <state>Kanton Bern</state>
        <zip>3010</zip>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Medizinische Klinik - Kantonspital Baden</name>
      <address>
        <city>Baden</city>
        <zip>5404</zip>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Service de Gastroentérologie &amp; Hépatologie, Hôspitaux Universtaires de Genève</name>
      <address>
        <city>Geneva</city>
        <zip>1211</zip>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Service de Gastrontèrologie et d'Hepatologie, Centre Hospitalier Universitaire Vaudois</name>
      <address>
        <city>Lausanne</city>
        <zip>1011</zip>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Centro di Epatologia - Clinica Luganese, Moncucco Hospital</name>
      <address>
        <city>Lugano</city>
        <zip>6900</zip>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Gastroenterologie und Hepatologie Kantospital St. Gallen</name>
      <address>
        <city>St. Gallen</city>
        <zip>9007</zip>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Klinik für Gastroenterologie und Hepatologie Universitätspital Zürich</name>
      <address>
        <city>Zürich</city>
        <zip>8091</zip>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location_countries>
    <country>Switzerland</country>
  </location_countries>
  <verification_date>May 2014</verification_date>
  <lastchanged_date>May 19, 2014</lastchanged_date>
  <firstreceived_date>November 6, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Venous Thrombosis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
